期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
Pseudomyxoma peritonei 被引量:5
1
作者 Katharine E Bevan Faheez Mohamed Brendan J Moran 《World Journal of Gastrointestinal Oncology》 SCIE CAS 2010年第1期44-50,共7页
Pseudomyxoma peritonei (PMP) is an uncommon "bor-derline malignancy" generally arising from a perforated appendiceal epithelial tumour. Optimal treatment involves a combination of cytoreductive surgery (CRS)... Pseudomyxoma peritonei (PMP) is an uncommon "bor-derline malignancy" generally arising from a perforated appendiceal epithelial tumour. Optimal treatment involves a combination of cytoreductive surgery (CRS) with heated intraperitoneal chemotherapy (HIPEC). Controversy persists regarding the pathological classification and its prognostic value. Computed tomography scanning is the optimal preoperative staging technique. Tumour marker elevations correlate with worse prognosis and increased recurrence rates. Following CRS with HIPEC, 5-year survival ranges from 62.5% to 100% for low grade, and 0%-65% for high grade disease. Treat-ment related morbidity and mortality ranges from 12 to 67.6%, and 0 to 9%, respectively. Surgery and HIPEC are the optimal treatment for PMP which is at best a "borderline" peritoneal malignancy. 展开更多
关键词 PSEUDOMYXOMA peritonei Cytoreductive surgery Heated INTRAPERITONEAL chemotherapy Jelly belly APPENDICEAL MUCINOUS tumour Peritoneal malignancy borderline malignancy
下载PDF
A Case Report: Cystic Clear Cell Tumor of Borderline Malignancy of the Ovary
2
作者 Yuko Matsubara Toru Fujioka +1 位作者 Keiichi Matsubara Akihiro Nawa 《Open Journal of Obstetrics and Gynecology》 2014年第7期391-394,共4页
Introduction:?Ovarian borderline clear cell tumor is a very rare tumor accounting for less than 1% of borderline ovarian tumors. Currently, only 30 cases of borderline clear cell tumors have been reported.?This border... Introduction:?Ovarian borderline clear cell tumor is a very rare tumor accounting for less than 1% of borderline ovarian tumors. Currently, only 30 cases of borderline clear cell tumors have been reported.?This borderline ovarian clear cell tumor often arises from endometriosis. But there are no definitive guidelines for the management of endometriosis with malignant transformation due to a lack of understanding of the mechanistic details that mediate the transformation of endometriosis into ovarian cancer. Case: A?52-year-old woman (G2 P2) who periodically underwent ultraso-nography over the course of 12 years in order to follow the endometrioma present in her left ovary. The diameter of the lesion was 46 mm and it remained largely unchanged. However, a solid region within the ovarian cyst was detected. After the surgery, the final pathological diagnosis was cystic clear cell tumor of borderline malignancy.?Conclusion: It reported that risk factors of malignant transformation are older age, postmenopausal status, and larger tumor diameters were associated with a higher prevalence of cancer development. But it is recommended that patients with endometriosis, regardless of patient age or tumor size, undergo careful monitoring to detect changes in growth or the formation of solid regions for as long as the lesion is present. 展开更多
关键词 borderline malignancy CLEAR Cell TUMOR OVARY
下载PDF
早期卵巢上皮性癌和交界性肿瘤保留生育功能相关问题 被引量:7
3
作者 彭芝兰 《中国实用妇科与产科杂志》 CAS CSCD 北大核心 2013年第5期334-339,共6页
文章分别对早期卵巢上皮性癌(EOC)及交界性卵巢癌(BOT)年轻患者要求保留生育功能治疗的术式、选择病例标准、术中注意事项、术后相关问题及妊娠结局进行讨论。在对EOC及BOT患者进行保留生育功能手术(FSS)治疗前应与患者充分讨论和交流,... 文章分别对早期卵巢上皮性癌(EOC)及交界性卵巢癌(BOT)年轻患者要求保留生育功能治疗的术式、选择病例标准、术中注意事项、术后相关问题及妊娠结局进行讨论。在对EOC及BOT患者进行保留生育功能手术(FSS)治疗前应与患者充分讨论和交流,使患者充分理解此种术式治疗后的生育潜在可能性和安全性。手术应由有经验的妇瘤医师施行,保证分期手术的准确性;术后多学科(妇科肿瘤医师、生殖医学专家、产科医师)会诊,共同治疗、随访,是获得妊娠良好结局和患者安全的保证。 展开更多
关键词 卵巢癌 交界性肿瘤 保留生育功能
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部